Flow Cytometry ready to shift gears in Cell Application
19 Dec 2013
Allied Market Research analysts recently prepared a Report named " Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020" This report by AMR explains to you about Flow Cytometry’s future market trend, growth, forecast and makes a proper analysis of it.
Cytometry refers to the diagnosis and study of cells and tissue in order to derive quantitative information. Such counting of cells and tissues is done by suspending them in a fluid stream and passing them through electrical detection apparatus. Their application is widely practiced in diagnosis of health disorders, more importantly in blood cancers. Apart from this, it is also used in clinical and research practice.
As per the report by AMR analysts, value of flow symmetry is expected to reach $6.5 billion by 2020 from $3 billion in 2012 growing at a CAGR of 30.9%. In order to boost up precisions and produce steadfast results many clinical institutions are adopting for innovative and path breaking technologies.
Analysts projected that Flow Cytometry is in the process of growth and with advanced Cytometry procedures like multi-parameter and multi-color has made its foot marks stronger in the market. They further estimated that developed economies and Asia Pacific region will see a rise in flow Cytometry market due high demand for improved health care system at an affordable cost. Analysts credit the growth of Flow Cytometry to factors like ageing population, increased chronic diseases, need for an improved healthcare system and enhance and effective diagnosis of medical conditions. Also, other conventional techniques are not able to deliver the solution on time, but Flow Cytometry is one prevalent technique that offers satisfactory solutions, especially in cancer diagnosis.
However, as per the experts flow Cytometry’s high cost of instrumentation will have a negative impact on its growth. Factors according to analysts that will hinder the growth of Flow Cytometry market are its large size of instrumentation and high cost, less awareness among prospect users and requirement of skilled individuals for its operation.
Analysts segmented the Flow Cytometry market into product, technology, end-users and application market. Instrument market under product segment has the highest revenue in share at present and will continue to remain till 2020. Accessibility, incorporation of imaging capabilities, Increase in modularity, targets and size reduction and availability of wavelengths are some factors that analysts think will be beneficial to instrument market. Also, reagent market under product segment is estimated to witness highest growth at a CAGR of 12% by the end of 2020. This is due to high applicability of reagents in fields like drug discovery, diagnosis etc.
Cell based and Bead based is two technologies that are being used in Flow Cytometry, as per experts. They also projected that cell technology will be highest grosser in terms of revenue till 2020; however bead technology will surpass it in terms of implementation.
As far as geographical location is concerned, North America accounted for highest revenue share of 43.5% i.e. $1.2 billion in 2011. It is estimated by AMR analysts to further reach a mark of $2.8 billion by 2020 at a CAGR of 10.1%.
Key firms listed in Flow Cytometry market are Becton, Dickinson & co, Beckman Coulter, Advanced analytical Technologies, Inc., Merck Millipore , Life technologies corp, Luminex Corp, eBioscience, Partech Amnis Corp and Morphosys AG.
Research Analyst at Allied Market Research
Deepa Tatkare has an experience of more than 3.5 years in market assessments and forecasts in healthcare & medical device industry. She is actively involved in providing critical insights on business research to clients with her subject matter expertize. Her profile includes planning, commissioning, and executing syndicate as well as customized research projects. She has successfully analyzed and presented data for studies related to medical devices, biotechnology, and pharmaceutical domains.